NICE CVD guideline
A concise summary of NICE's evidence-based clinical guideline on lipid modification for the prevention of cardiovascular disease
ABCD position on cardiovascular impact of glucose-lowering drugs
Key recommendations from the ABCD position statement on new glucose-lowering drugs concerning their cardiovascular impact on people with diabetes
NHS lipid management pathway
This Guidelines summary covers key recommendations from national guidance on lipid management for the primary and secondary prevention of cardiovascular disease
COVID-19 rapid guideline on VITT
This Guidelines summary covers vaccine-induced immune thrombocytopenia and thrombosis, a syndrome that has been reported in rare cases after COVID-19 vaccination
NICE atrial fibrillation guideline
A clear summary of NICE’s guideline on atrial fibrillation management
Self Care Forum venous disease fact sheet
A summary of recommendations for advising patients and the public on managing venous disease
CaReMeUK heart failure algorithm
A heart failure management algorithm modified from the NICE guideline, Chronic heart failure in adults: diagnosis and management
CaReMeUK cardiovascular risk optimisation algorithm
A guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with type 2 diabetes and atherosclerotic cardiovascular disease
HEART UK Managing hyperlipidaemia and COVID-19
A summary of collated current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19
NICE guideline on acute coronary syndromes
A brief summary of NICE’s clinical guideline on the management of acute coronary syndromes, which covers rehabilitation and aims to improve survival and quality of life.
AWMSG advice on oral anticoagulation for non-valvular atrial fibrillation
Recommendations for primary care on the role of oral anticoagulant treatment in people with non-valvular atrial fibrillation.
BSR giant cell arteritis guideline
This summary outlines the general principles of identifying and treating patients with giant cell arteritis in primary care and specialist settings. It is recommended that general practitioners refer patients with suspected giant cell arteritis to a clinician with appropriate specialist expertise.
NICE stable angina guideline
A brief summary of NICE's clinical guideline on the management of stable angina. Includes care pathway algorithm, counselling, and secondary prevention.
Consensus guideline on the holistic management of patients requiring anticoagulation
This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of an educational grant from Bayer plc.
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing
This useful summary covers diagnosis and initial management, outpatient treatment for low-risk pulmonary embolism, anticoagulation treatment for suspected or confirmed deep vein thrombosis or pulmonary embolism, and information and support for people having anticoagulation treatment
NICE abdominal aortic aneurysm guideline
This Guidelines summary covers diagnosis, monitoring and reducing the risk of rupture, and emergency transfer to regional vascular services
NICE FH guideline
Summary of NICE guidance on the identification and management of familial hypercholesterolaemia, which includes diagnostic criteria and when to refer.
NICE hypertension guideline
A brief guide on the diagnosis and management of hypertension, includes visual summaries on treatment and choice of antihypertensive drug.
NICE stroke and TIA guideline
This concise summary covers the rapid recognition of symptoms and diagnosis of stroke and transient ischaemic attack.
NICE hypertension in pregnancy guideline
This summary covers the diagnosis and management of hypertension during pregnancy, labour, and birth.
SIGN cardiac arrhythmias guideline
Read the latest recommendations on the management of atrial fibrillation and ventricular arrhythmias in acute coronary syndrome, coronary heart disease, and left-ventricular dysfunction as well as arrhythmias associated with cardiac arrest and coronary artery bypass graft.
Stable peripheral arterial disease guideline
This guideline was developed by a multidisciplinary expert panel: Begg A et al with the support of a grant from Bayer plc.
Stable coronary artery disease guideline
This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of a grant from Bayer plc.
NICE chronic heart failure guideline
This summary of the NICE heart failure guideline covers management and monitoring treatment. Includes algorithms on diagnosis and therapies.
SIGN stable angina guideline
This summary includes management algorithms for patients with suspected angina, and patients with a definite diagnosis of stable angina.
Management of palpitations in primary care guideline
How do you manage palpitations in primary care? This summary covers assessment and examination, risk stratification, and indications for referral.
SIGN CVD guideline
This summary covers estimation of cardiovascular event risk, lifestyle interventions, and pharmacological therapy.
NICE chest pain guideline
An easy-to-read guideline summary on the assessment and diagnosis of acute and stable chest pain, including management and referral for suspected ACS.
GOSH blood pressure monitoring guideline
A concise summary of Great Ormond Street Hospital guidance on monitoring blood pressure in infants, children, and young people.
NICE varicose veins guideline
Summary of NICE's guideline on the diagnosis and management of varicose veins in adults aged 18 years and over.
SIGN stroke and dysphagia guideline
This summarises SIGN's guideline on the identification and management of dysphagia in stroke patients.
SIGN chronic heart failure guideline
This summary covers diagnosis, lifestyle, and pharmacological interventions, and includes a diagnostic algorithm for suspected chronic heart failure.
SIGN antithrombotics guideline
A clear SIGN guideline summary exploring antiplatelet and anticoagulant agents and indications for their use, including cardiac and cerebrovascular disease.
JBS cardiovascular disease prevention guideline
A clear summary of JBS' recommendations on the prevention of cardiovascular disease. Includes an algorithm to help with risk assessment and management.
Educational resources
Empagliflozin (Jardiance®) 10mg film-coated tablets SMC2396
The production of this Guidelines summary card has been commissioned by the Boehringer Ingelheim and Lilly Alliance.
View Jardiance® (empagliflozin) prescribing and adverse event reporting information for Great Britain and Northern Ireland.
PC-GB-105816 October 2021
Updates in best practice management of venous thromboembolism
These promotional videos have been funded by Bristol Myers Squibb on behalf of the BMS / Pfizer Alliance and developed in conjunction with Guidelines. The promotional content on this page is intended for UK healthcare professionals only.
View ELIQUIS (apixaban) prescribing and adverse event reporting information
432-GB-2100782 | Date of preparation: September 2021
Modern management of stroke prevention in non-valvular atrial fibrillation
These promotional videos have been funded by Bristol Myers Squibb on behalf of the BMS / Pfizer Alliance and developed in conjunction with Guidelines. The promotional content on this page is intended for UK healthcare professionals only.
View ELIQUIS (apixaban) prescribing and adverse event reporting information
432-GB-2100689 | Date of preparation: August 2021
Calculating renal function in patients with atrial fibrillation
This animation has been developed and funded by the Bristol Myers Squibb/Pfizer Alliance and is intended for UK healthcare professionals.
432-GB-2100230 June 2021
The holistic management of patients requiring anticoagulation
This video has been commissioned and funded by Bayer plc and developed in partnership with Guidelines.
View Xarelto▼(rivaroxaban) prescribing information and adverse event reporting
PP-XAR-GB-1924 January 2021